HEALIOS K
Cell & Gene Therapy
Overview
株式会社ヘリオスは人類の可能性を、人類が手にした最高の技術革新であるバイオ革命という科学技術力で爆発的に広げ、日本の誇るiPSC再生医薬品を活用し、世界中で病に苦しむ患者さんに 癒しを届けます。.
Funding and backers
Backers
1
Betavc
Momentum
0/100
no fresh signals
Last sign of life
1 mo ago
a posting or a news item
Backed byfrom the funds' portfolios and accelerator catalogs
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
Q-Immune provides cutting-edge real-time protein network analysis for CAR-T cells, enabling accurate efficacy prediction, optimized CAR-T…
Profluent is a company founded in 2022 that trains large language models on protein sequences to design new functional proteins. It…
We're on a mission to fulfill the promise of genetic medicine for all patients. At Addition, we are advancing a pipeline of therapeutics to…
At Jaguar Gene Therapy, we believe in a world where patients and families won’t have to hear those words. Our mission is to accelerate…
Search for: At SonomaBio we believe in balance. Sonoma Biotherapeutics is a clinical-stage biotechnology company developing engineered…
Molecular Cell Architecture - Life at the highest resolution. Pixelgen Technologies' mission is to provide insights into biology at the…
Connections
List
Graph
Found in company registers, site code, DNS and hiring. Each connection shows how sure we are and the evidence, with its source and date.
Shared investors
BetavcVia a fund
Click a company to open it. Dashed lines are likely connections. The second step of the network is part of the Pro plan.
Owner
Same company
Same group
Likely
News
Report
Report
HEALIOS K.K. to Present at Jefferies Global Healthcare Conference
NEW YORK, May 14, 2026 (GLOBE NEWSWIRE) -- HEALIOS K.K. (
Read more
Report
Report
Healios K.K. to Present at Jefferies Global Healthcare Conference
NEW YORK, Nov. 11, 2025 (GLOBE NEWSWIRE) -- HEALIOS K.K. (
Read more
Report
Healios K.K. Advances in Regenerative Medicine
Healios KK (JP:4593) has released an update.Pick the best stocks and maximize your portfolio:Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!Easily identify outperforming stocks and invest smarter with Top Smart Score StocksH
Read more
Report
HEALIOS K.K. Increases Investment in Athersys by Fully Exercising Warrant to Acquire Additional Shares
Athersys, Inc. announced today that its partner in Japan, HEALIOS K.K., exercised in full its warrant to purchase shares of Athersys common stock. Healios purchased 4,000,000 shares at a price of $1.76 per share in accordance with the terms of the warrant
Read more
Report
